Attenuation of receptor-dependent and -independent vasoconstriction in the human radial artery

Shackcloth, Michael J.; Conant, Alan R.; Thekkudan, Joyce; Ghotkar, Sanjay; Simpson, Alec W.M.; Dihmis, Walid C.
October 2008
European Journal of Cardio-Thoracic Surgery;Oct2008, Vol. 34 Issue 4, p839
Academic Journal
Abstract: Background: Vasodilator strategies used to treat bypass grafts in the operating theatre, such as nitrates, phosphodiesterase inhibitors and calcium channel antagonists have a broad but short-lived effect against a variety of vasoconstrictor stimuli. Treatments that react irreversibly with proteins modulating vasoconstriction have the advantage that their effects can last well into the postoperative period. In addition systemic effects are avoided as the treatment is localised to the treated graft. This study investigated the use of two clinically applied drugs; fluphenazine (SKF7171A, HCl), an irreversible calmodulin antagonist and minoxidil sulphate, an irreversible potassium channel opener. Treatments were tested against receptor and non-receptor-mediated contraction in the human radial artery. Method: Isometric tension was measured in response to angiotensin II, KCl and vasopressin in 108 radial artery rings (taken from 31 patients undergoing coronary artery bypass grafting). Control responses were compared with rings pretreated with fluphenazine or minoxidil sulphate. Vasopressin responses were also compared in the presence of glyceryl trinitrate or the reversible Rho kinase inhibitor Y27632. Results: Fluphenazine pretreatment significantly suppressed vasoconstriction to all agonists tested. Maximal responses to angiotensin II, vasopressin and KCl were reduced by 42±19%, 35±8% and 48±15% respectively, without any measurable effect on the EC50. Minoxidil sulphate showed no discernable effect. Vasopressin-induced contraction was also reduced by high levels of glyceryl trinitrate (220μM; 50μg/ml) or 10μM Y27632. Conclusions: The irreversible calmodulin antagonist fluphenazine has potential to be developed as an inhibitor of contraction in arterial graft vessels. The involvement of Rho kinase indicates that other vasoconstrictors and surgical stress can sensitize radial artery to vasopressin-induced contraction. Strategies targeting this pathway also have future potential.


Related Articles

  • Coronary artery bypass grafting in Canada: National and provincial mortality trends, 1992-1995. Ghali, William A.; Quan, Hude; Brant, Rollin // CMAJ: Canadian Medical Association Journal;07/14/98, Vol. 159 Issue 1, p25 

    Examines Canadian trends in rates of in-hospital death after coronary artery bypass grafting (CABG) and compares provicial risk-adjusted death rates. Methods; Results; Interpretation and conclusions.

  • Coronary Artery Bypass Grafting for Patients with Aortoiliac Occlusive Disease. Hirose, Hitoshi; Nakano, Hidetaka; Amano, Atsushi; Takahashi, Akihito // Vascular & Endovascular Surgery;Jul/Aug2002, Vol. 36 Issue 4, p285 

    Presents a study that examined coronary artery bypass grafting for patients with aortoiliac occlusive disease. Background on the risk of leg ischemia posed by harvest of the internal thoracic artery in patients with aortoiliac occlusive disease; Medical history of the patients; Results and...

  • Antiplatelet therapy at the time of coronary artery surgery: can a personalized approach improve outcomes? Petricevic, Mate; Biocina, Bojan; Lekic, Ante; Gabelica, Rajka // European Journal of Cardio-Thoracic Surgery;May2014, Vol. 45 Issue 5, p951 

    A letter to the editor is presented in response to the article "Antiplatelet therapy at the time of coronary artery bypass grafting: a multicentre cohort study" by Kremke et al. in the 2013 issue.

  • CABG more cost effective than PCI for patients with diabetes. Costa, Samantha; Ellis, Brian; Foster, Melissa; Kalvaitis, Katie; Volansky, Rob // Endocrine Today;Dec2012, Vol. 10 Issue 12, p27 

    The article reports that based on the FREEDOM trial, the cost of coronary artery bypass grafting (CABG) is more economical compared to percutaneous coronary intervention (PCI), which according to Dr. Elizabeth A. Magnuson was carried out to provide insight into the relative value of CABG and PCI.

  • Experts put FREEDOM findings in perspective. Foster, Melissa // Endocrine Today;Dec2012, Vol. 10 Issue 12, p37 

    The article reports on data from the FREEDOM trial showing that for patients with diabetes and multivessel coronary artery, coronary artery bypass grafting (CABG) is the most recommended treatment strategy.

  • Redo off-pump coronary artery bypass grafting via left thoracotomy. Duvan, I.; Kurtoglu, M.; Ates, S.; Onuk, B. E.; Sungur, P.; Karacan, I. S. // Journal of Cardiothoracic Surgery;2013, Vol. 8 Issue Suppl 1, p1 

    An abstract of the article "Redo off-pump coronary artery bypass grafting via left thoracotomy" by I. Duvan and colleagues is presented.

  • Acute Hemodynamic Response to Acapella in Phase 1 Cardiac Rehabilitation Following Coronary Artery Bypass Graft Surgery. Fozia; Moiz, Jamal Ali; Shama, Divya M.; Ejaz Hussain, M. // Physiotherapy & Occupational Therapy Journal;Apr-Jun2013, Vol. 6 Issue 2, p65 

    Purpose: The purpose of this study was to evaluate the acute hemodynamic response to Acapella in patients underwent coronary artery bypass graft surgery (CABG). Methods: Fifteen (n=15, mean age: 57.6±9.8 years) post CABG patients were selected for this study from cardiothoracic unit of...

  • Gender Differences Are Reflected in Cost of Heart Surgery. Rose, Verna L. // American Family Physician;8/1/1999, Vol. 60 Issue 2, p603 

    Looks at a study of patients undergoing coronary artery bypass graft (CABG) surgery and the gender difference in the cost of undergoing CABG. Amount of time women spent on mechanical ventilation following surgery; Severity of coronary disease before surgery; Recommendation for further studies.

  • Coronary artery bypass graft (CABG) and the diabetic patient: current perspectives. Hoffman, Darryl M.; Tranbaugh, Robert F. // Research Reports in Clinical Cardiology;2014, Vol. 5, p57 

    Diabetes increases both the severity and the risks of coronary artery disease. For such patients, revascularization by coronary artery bypass grafting (CABG) has consistently improved survival and event free survival in multiple studies compared to percutaneous revascularization (PCI). Evolving...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics